John Dingell actually said...

"I have got some legislation to address that and I hope that we will be shortly addressing it here in this committee."

"At the end of the day, American consumers and patients are facing 3 problems: 1) the drugs, they need to be available and affordable; 2) are there drugs they need safe; and 3) are they efficacious? Do..."

"I hope that we don't take the failure, for whatever reason, of this project to mean that all renewable energy projects are bad investments."

"Do you have authority at FDA or at HHS to waive any of the requirements with regard to efficacy, good manufacturing practices, or safety, yes or no, in the event of shortage?"